Table 4 Patient-reported outcomes, shoulder range of motion, and use of analgesics before and after the progressive shoulder exercise intervention on 18 patients
Outcome measures | Baseline score Mean (95% CI) | Follow-up score Mean (95% CI) | Change score Mean (95% CI) |
|---|---|---|---|
WOOS (0–100, 100 best) | 42 (33; 52) | 65 (55; 76) | 23 (13; 33)* |
DASH (0–100, 100 worst) | 42 (35; 50) | 30 (22; 37) | − 13 (− 19; − 6)* |
EQ-5D-5L | |||
 Utility index (− 1, 1 best) | 0.66 (0.61; 0.72) | 0.73 (0.67; 0.79) | 0.06 (0.001; 0.14) |
 VAS (0–100, 100 best) | 65 (54; 75) | 73 (62; 84) | 8 (6; 22) |
Subjective shoulder value (0–100, 100 best) | 45 (37; 53) | 62 (53;71) | 17 (5; 30)** |
Pain (0–100, 100 worst) | |||
 VAS at rest | 51 (38; 64) | 28 (17; 40) | − 23 (− 36; − 9)** |
 VAS during activity | 66 (54; 77) | 39 (25; 52) | − 27 (− 39: − 15)* |
 Sleep disturbing pain (yes/no) | 17/1 | 9/8a | 0.005b |
AROM | |||
 Flexion, degrees | 110 (96; 125) | 127 (112; 143) | 17 (3; 31) |
 Abduction, degrees | 99 (85; 112) | 124 (110; 138) | 25 (13; 37) |
Usage of analgesics | |||
 Yes/no | 18/0 | 15/3 |  |
 Daily/weekly/never | 10/7/0a | 9/6/3 |  |
 Paracetamol (yes/no) | 18/0 | 13/5 |  |
 NSAIDs (yes/no) | 3/15 | 3/15 |  |
 Opiods (yes/no) | 2/16 | 0/18 |  |